Patents by Inventor Janan Jona
Janan Jona has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8183293Abstract: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related diseases and conditions. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives.Type: GrantFiled: December 18, 2008Date of Patent: May 22, 2012Assignee: Amgen Inc.Inventors: Mark Grillo, An-Rong Li, Jiwen Liu, Julio C. Medina, Yongli Su, Yingcai Wang, Janan Jona, Alan Allgeier, Jacqueline Milne, Jerry Murry, Joseph F. Payack, Thomas Storz
-
Patent number: 7873399Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: GrantFiled: January 30, 2007Date of Patent: January 18, 2011Assignee: Animas CorporationInventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Publication number: 20090275659Abstract: Compounds, pharmaceutical compositions and methods are provided that are useful in the treatment of inflammatory and immune-related diseases and conditions. In particular, the invention provides compounds which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer. The subject compounds are carboxylic acid derivatives.Type: ApplicationFiled: December 18, 2008Publication date: November 5, 2009Applicant: Amgen Inc.Inventors: Mark Grillo, An-Rong Li, Jiwen Liu, Julio C. Medina, Yongli Su, Yingcai Wang, Janan Jona, Alan Allgeier, Jacqueline Milne, Jerry Murry, Joseph F. Payack, Thomas Storz
-
Publication number: 20070142721Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: ApplicationFiled: January 30, 2007Publication date: June 21, 2007Inventors: Bret Berner, Chia-Ming Chiang, Michael Garrison, Janan Jona, Russell Potts, Janet Tamada, Michael Tierney
-
Publication number: 20070110802Abstract: The present invention relates to a process of wet granulation, and specifically wet granulation of material that is susceptible to convert from anhydrous form to hydrate form.Type: ApplicationFiled: November 14, 2006Publication date: May 17, 2007Inventors: Janan Jona, Sekhar Kanapuram, Dominick Daurio
-
Patent number: 7174199Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: GrantFiled: November 5, 2004Date of Patent: February 6, 2007Assignee: Animas Technologies, LLCInventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Publication number: 20050215872Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: ApplicationFiled: November 5, 2004Publication date: September 29, 2005Inventors: Bret Berner, Chia-Ming Chiang, Michael Garrison, Janan Jona, Russell Potts, Janet Tamada, Michael Tierney
-
Patent number: 6850790Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: GrantFiled: May 14, 2003Date of Patent: February 1, 2005Assignee: Cygnus, Inc.Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Publication number: 20030195403Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: ApplicationFiled: May 14, 2003Publication date: October 16, 2003Applicant: Cygnus, Inc.Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Patent number: 6594514Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: GrantFiled: December 20, 2001Date of Patent: July 15, 2003Assignee: Cygnus, Inc.Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Publication number: 20020091312Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: ApplicationFiled: December 20, 2001Publication date: July 11, 2002Applicant: Cygnus, Inc.Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Patent number: 6356776Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: GrantFiled: August 16, 2000Date of Patent: March 12, 2002Assignee: Cygnus, Inc.Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Patent number: 6144869Abstract: Methods and devices are provided for measuring the concentration of target chemical analytes present in a biological system. Device configuration and/or measurement techniques are employed in order to reduce the effect of interfering species on sensor sensitivity. One important application of the invention involves a method and device for monitoring blood glucose values.Type: GrantFiled: May 11, 1999Date of Patent: November 7, 2000Assignee: Cygnus, Inc.Inventors: Bret Berner, Chia-Ming Chiang, Michael D. Garrison, Janan Jona, Russell O. Potts, Janet A. Tamada, Michael J. Tierney
-
Patent number: 6071531Abstract: Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.Type: GrantFiled: June 28, 1999Date of Patent: June 6, 2000Assignee: Ortho-McNeil Pharmaceutical, Inc.Inventors: Janan Jona, Jay Audett, Noel Singh
-
Patent number: 5972377Abstract: Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women.Type: GrantFiled: October 2, 1998Date of Patent: October 26, 1999Assignee: Cygnus, Inc.Inventors: Janan Jona, Jay Audett, Noel Singh
-
Patent number: 5902603Abstract: High capacity drug reservoirs are provided for incorporation into transdermal drug delivery systems. The drug reservoirs are hydrogels formulated from polyurethanes crosslinked with diisocyanate crosslinking agents or cured with radiation in the presence of a photoinitator. Drug loading as high as 65 to 70 wt. % or higher can be achieved by absorbing drug formulation into the reservoir after hydrogel synthesis. Methods for making and using transdermal systems containing such reservoirs are provided as well.Type: GrantFiled: September 13, 1996Date of Patent: May 11, 1999Assignee: Cygnus, Inc.Inventors: Tung-Fen Chen, Chia-Ming Chiang, Janan Jona, Priti Joshi, Asha Ramdas
-
Patent number: 5891461Abstract: Transdermal administration of olanzapine and pharmaceutically acceptable acid addition salts thereof is described. The method involves treating an individual suffering from or susceptible to psychosis, acute mania or mild anxiety states, particularly those afflicted with schizophrenia or schizophreniform illnesses, by administering olanzapine or a salt thereof through the skin or mucosal tissue, for a time period and at an administration rate effective to alleviate the symptoms of the disease. Pharmaceutical formulations and drug delivery systems for administering olanzapine are provided as well.Type: GrantFiled: September 14, 1995Date of Patent: April 6, 1999Assignee: Cygnus, Inc.Inventors: Janan Jona, Priti Joshi, Asha Ramdas
-
Patent number: 5876746Abstract: Compositions and methods for preventing ovulation in a woman are provided, as well as compositions and methods for female hormone replacement therapy. The compositions can be administered by the use of a transdermal patch. The patch will administer 17-deacetyl norgestimate alone or in combination with an estrogen such as ethinyl estradiol to women via an adhesive matrix of a silicone and/or polyisobutylene.Type: GrantFiled: June 6, 1996Date of Patent: March 2, 1999Assignee: Cygnus, Inc.Inventors: Janan Jona, Jay Audett, Noel Singh
-
Patent number: 5693335Abstract: A combination permeation enhancer for increasing the permeability of skin to sex steroids such as estrogens and progestogens comprising a polyhydric thioalcohol of 2 to 6 carbon atoms having at least one mercapto group and at least one hydroxy group and an aliphatic carboxylic acid of 8 to 24 carbon atoms or an ester thereof.Type: GrantFiled: June 7, 1995Date of Patent: December 2, 1997Assignee: Cygnus, Inc.Inventors: Jun Xia, Janan Jona, Chia-Ming Chiang